Search

Your search keyword '"Tiribelli, Mario"' showing total 23 results
Start Over Author "Tiribelli, Mario" Journal annals of hematology
23 results on '"Tiribelli, Mario"'

2. Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials

Author

Luciano, Luigia, Latagliata, Roberto, Gugliotta, Gabriele, Annunziata, Mario, Tiribelli, Mario, Martino, Bruno, Sica, Antonello, Esposito, Maria Rosaria, Bocchia, Monica, Galimberti, Sara, Sorà, Federica, Albano, Francesco, Palmieri, Raffaele, Pregno, Patrizia, Dragani, Matteo, Iovine, Maria, Sica, Simona, Iurlo, Alessandra, Castagnetti, Fausto, Rosti, Gianantonio, and Breccia, Massimo

Published
2023
Full Text
View/download PDF

5. Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib

Author

Caocci, Giovanni, Mulas, Olga, Capodanno, Isabella, Bonifacio, Massimiliano, Annunziata, Mario, Galimberti, Sara, Luciano, Luigiana, Tiribelli, Mario, Martino, Bruno, Castagnetti, Fausto, Binotto, Gianni, Pregno, Patrizia, Stagno, Fabio, Abruzzese, Elisabetta, Bocchia, Monica, Gozzini, Antonella, Albano, Francesco, Fozza, Claudio, Luzi, Debora, Efficace, Fabio, Simula, Maria Pina, Scaffidi, Luigi, Baratè, Claudia, De Gregorio, Fiorenza, Stella, Rossella, Gugliotta, Gabriele, Pirillo, Francesca, Trawinska, Malgorzata Monika, Sicuranza, Anna, Cattaneo, Daniele, Attolico, Immacolata, Scalzulli, Emilia, Iurlo, Alessandra, Foà, Robin, Breccia, Massimo, and La Nasa, Giorgio

Published
2021
Full Text
View/download PDF

6. Correlation between IPSET-t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience

Author

Tosoni, Luca, primary, Morelli, Gianluca, additional, Zannier, Maria Elena, additional, Lazzarotto, Davide, additional, Filì, Carla, additional, Simeone, Erica, additional, Battaglia, Giulia, additional, Callegari, Chiara, additional, Fanin, Matteo, additional, Damiani, Daniela, additional, Fanin, Renato, additional, and Tiribelli, Mario, additional

Published
2023
Full Text
View/download PDF

7. Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors

Author

Mulas, Olga, Caocci, Giovanni, Stagno, Fabio, Bonifacio, Massimiliano, Annunziata, Mario, Luciano, Luigiana, Orlandi, Ester Maria, Abruzzese, Elisabetta, Sgherza, Nicola, Martino, Bruno, Albano, Francesco, Galimberti, Sara, Pregno, Patrizia, Bocchia, Monica, Castagnetti, Fausto, Tiribelli, Mario, Binotto, Gianni, Gozzini, Antonella, Capodanno, Isabella, Fozza, Claudio, Luzi, Debora, Efficace, Fabio, Simula, Maria Pina, Scaffidi, Luigi, De Gregorio, Fiorenza, Elena, Chiara, Trawinska, Malgorzata Monika, Cattaneo, Daniele, Attolico, Imma, Baratè, Claudia, Pirillo, Francesca, Sicuranza, Anna, Gugliotta, Gabriele, Stella, Rossella, Scalzulli, Emilia, Iurlo, Alessandra, Foà, Robin, Breccia, Massimo, and La Nasa, Giorgio

Published
2020
Full Text
View/download PDF

8. Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practice

Author

Breccia, Massimo, Baratè, Claudia, Benevolo, Giulia, Bonifacio, Massimiliano, Elli, Elena Maria, Guglielmelli, Paola, Maffioli, Margherita, Malato, Alessandra, Mendicino, Francesco, Palumbo, Giuseppe Alberto, Pugliese, Novella, Rossi, Elena, Rumi, Elisa, Sant’Antonio, Emanuela, Ricco, Alessandra, Tiribelli, Mario, and Palandri, Francesca

Published
2020
Full Text
View/download PDF

9. Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline

Author

Crugnola, Monica, Castagnetti, Fausto, Breccia, Massimo, Ferrero, Dario, Trawinska, Malgorzata Monika, Abruzzese, Elisabetta, Annunziata, Mario, Stagno, Fabio, Tiribelli, Mario, Binotto, Gianni, Bonifacio, Massimiliano, Fava, Carmen, Iurlo, Alessandra, Bucelli, Cristina, Mansueto, Giovanna, Gozzini, Antonella, Falzetti, Franca, Montefusco, Enrico, Crisà, Elena, Gugliotta, Gabriele, Russo, Sabina, Cedrone, Michele, RussoRossi, Antonella, Pregno, Patrizia, Isidori, Alessandro, Mauro, Endri, Atelda, Romano, Giglio, Gianfranco, Celesti, Francesca, Sorà, Federica, Storti, Sergio, D’Addosio, Adam, Galimberti, Sara, Orlandi, Ester, Calistri, Elisabetta, Bocchia, Monica, Cavazzini, Francesco, Rege Cambrin, Giovanna, Orofino, Nicola, Luciano, Luigiana, Sgherza, Nicola, Rosti, Gianantonio, Latagliata, Roberto, and Capodanno, Isabella

Published
2019
Full Text
View/download PDF

11. Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis

Author

Breccia, Massimo, Luciano, Luigiana, Pugliese, Novella, Rossi, Elena, Tiribelli, Mario, Scalzulli, Emilia, Bonifacio, Massimiliano, Martino, Bruno, Latagliata, Roberto, Benevolo, Giulia, Caocci, Giovanni, Binotto, Gianni, Martinelli, Vincenzo, Cavo, Michele, Pane, Fabrizio, De Stefano, Valerio, Foà, Robin, and Palandri, Francesca

Published
2019
Full Text
View/download PDF

12. Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib

Author

Breccia, Massimo, Bartoletti, Daniela, Bonifacio, Massimiliano, Palumbo, Giuseppe A., Polverelli, Nicola, Abruzzese, Elisabetta, Bergamaschi, Micaela, Tieghi, Alessia, Tiribelli, Mario, Iurlo, Alessandra, Cavazzini, Francesco, Sgherza, Nicola, Binotto, Gianni, Isidori, Alessandro, D’Adda, Mariella, Crugnola, Monica, Bosi, Costanza, Heidel, Florian, Molica, Matteo, Scaffidi, Luigi, Cattaneo, Daniele, Latagliata, Roberto, Auteri, Giuseppe, Lemoli, Roberto M., Fanin, Renato, Russo, Domenico, Aversa, Franco, Cuneo, Antonio, Semenzato, Gianpietro, Catani, Lucia, Cavo, Michele, Vianelli, Nicola, Foà, Robin, and Palandri, Francesca

Published
2019
Full Text
View/download PDF

13. Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series

Author

Iurlo, Alessandra, Galimberti, Sara, Abruzzese, Elisabetta, Annunziata, Mario, Bonifacio, Massimiliano, Latagliata, Roberto, Pregno, Patrizia, Ferrero, Dario, Sorà, Federica, Orlandi, Ester Maria, Fava, Carmen, Cattaneo, Daniele, Bucelli, Cristina, Binotto, Gianni, Pungolino, Ester, Tiribelli, Mario, Gozzini, Antonella, Gugliotta, Gabriele, Castagnetti, Fausto, Stagno, Fabio, Rege-Cambrin, Giovanna, Martino, Bruno, Luciano, Luigiana, Breccia, Massimo, Sica, Simona, Bocchia, Monica, Pane, Fabrizio, Saglio, Giuseppe, Rosti, Gianantonio, Specchia, Giorgina, Cortelezzi, Agostino, and Baccarani, Michele

Published
2017
Full Text
View/download PDF

14. Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemia

Author

Tiribelli, Mario, Latagliata, Roberto, Luciano, Luigiana, Castagnetti, Fausto, Gozzini, Antonella, Cambrin, Giovanna Rege, Annunziata, Mario, Stagno, Fabio, Pregno, Patrizia, Albano, Francesco, Abruzzese, Elisabetta, Musto, Pellegrino, Montefusco, Enrico, Fava, Carmen, Fanin, Renato, Pane, Fabrizio, Rosti, Gianantonio, Breccia, Massimo, Alimena, Giuliana, and Vigneri, Paolo

Published
2013
Full Text
View/download PDF

16. Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practice

Author

Breccia, Massimo, primary, Baratè, Claudia, additional, Benevolo, Giulia, additional, Bonifacio, Massimiliano, additional, Elli, Elena Maria, additional, Guglielmelli, Paola, additional, Maffioli, Margherita, additional, Malato, Alessandra, additional, Mendicino, Francesco, additional, Palumbo, Giuseppe Alberto, additional, Pugliese, Novella, additional, Rossi, Elena, additional, Rumi, Elisa, additional, Sant’Antonio, Emanuela, additional, Ricco, Alessandra, additional, Tiribelli, Mario, additional, and Palandri, Francesca, additional

Published
2019
Full Text
View/download PDF

20. Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib

Author

Breccia, Massimo, primary, Bartoletti, Daniela, additional, Bonifacio, Massimiliano, additional, Palumbo, Giuseppe A., additional, Polverelli, Nicola, additional, Abruzzese, Elisabetta, additional, Bergamaschi, Micaela, additional, Tieghi, Alessia, additional, Tiribelli, Mario, additional, Iurlo, Alessandra, additional, Cavazzini, Francesco, additional, Sgherza, Nicola, additional, Binotto, Gianni, additional, Isidori, Alessandro, additional, D’Adda, Mariella, additional, Crugnola, Monica, additional, Bosi, Costanza, additional, Heidel, Florian, additional, Molica, Matteo, additional, Scaffidi, Luigi, additional, Cattaneo, Daniele, additional, Latagliata, Roberto, additional, Auteri, Giuseppe, additional, Lemoli, Roberto M., additional, Fanin, Renato, additional, Russo, Domenico, additional, Aversa, Franco, additional, Cuneo, Antonio, additional, Semenzato, Gianpietro, additional, Catani, Lucia, additional, Cavo, Michele, additional, Vianelli, Nicola, additional, Foà, Robin, additional, and Palandri, Francesca, additional

Published
2018
Full Text
View/download PDF

21. Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series.

Author

Iurlo, Alessandra, Galimberti, Sara, Abruzzese, Elisabetta, Annunziata, Mario, Bonifacio, Massimiliano, Latagliata, Roberto, Pregno, Patrizia, Ferrero, Dario, Sorà, Federica, Orlandi, Ester Maria, Fava, Carmen, Cattaneo, Daniele, Bucelli, Cristina, Binotto, Gianni, Pungolino, Ester, Tiribelli, Mario, Gozzini, Antonella, Gugliotta, Gabriele, Castagnetti, Fausto, and Stagno, Fabio

Subjects
TREATMENT of chronic myeloid leukemia, CHRONIC myeloid leukemia, DASATINIB, ADVERSE health care events, RETROSPECTIVE studies, PATIENTS, THERAPEUTICS, COMPARATIVE studies, GENES, RESEARCH methodology, MEDICAL cooperation, PLEURAL effusions, RESEARCH, DISEASE relapse, EVALUATION research, TREATMENT effectiveness, DYADIC Adjustment Scale
Abstract

Pleural effusion (PE) represents the leading cause of dasatinib (DAS) discontinuation. However, the pathogenic mechanism of this adverse event (AE) is unknown and its management unclear. We investigated if a DAS dose reduction after the first PE would prevent the recurrence of this AE. We retrospectively collected data on all the cases of PE in CML-chronic phase (CP) DAS-treated patients from November 2005 to February 2017 in 21 Italian hematological centers. We identified 196 cases of PE in a series of 853 CML-CP DAS-treated patients (incidence 23.0%). DAS starting dose was 100 mg/day in 70.4% of patients, less than 100 mg/day in 14.3%, and more than 100 mg/day in the remaining cases. Median time from DAS start to PE was 16.6 months. At first PE development, 28.6% of patients were in MMR, and 37.8% in deep molecular response (DMR). DAS was temporary interrupted in 71.9% of cases, with a dose reduction in 59.2%. Recurrence was observed in 59.4% of the cases. Treatment was definitively discontinued due to PE in 29.1% of the cases. Interestingly, among patients whose DAS dosage was reduced, 59.5% experienced PE recurrence. DAS dose reduction after the first episode of PE did not prevent recurrence of this AE. Therefore, once a MMR or a DMR is achieved, different strategies of DAS dose management can be proposed prior to the development of PE, such as daily dose reduction or, as an alternative option, an on/off treatment with a weekend drug holiday. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

23. Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemia

Author

Tiribelli, Mario, primary, Latagliata, Roberto, additional, Luciano, Luigiana, additional, Castagnetti, Fausto, additional, Gozzini, Antonella, additional, Cambrin, Giovanna Rege, additional, Annunziata, Mario, additional, Stagno, Fabio, additional, Pregno, Patrizia, additional, Albano, Francesco, additional, Abruzzese, Elisabetta, additional, Musto, Pellegrino, additional, Montefusco, Enrico, additional, Fava, Carmen, additional, Fanin, Renato, additional, Pane, Fabrizio, additional, Rosti, Gianantonio, additional, Breccia, Massimo, additional, Alimena, Giuliana, additional, and Vigneri, Paolo, additional

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results